We are increasingly exposed to the impact of climate change, air quality degradation and emerging diseases. The number of people affected by respiratory conditions is growing significantly, yet resources to meet their care needs continue to decline.
In this sense, research plays a fundamental role in connecting the actors in the healthcare system, providing quality, science-based information for decision-making, and promoting new knowledge for a healthy, prosperous and more equitable global society.
“The 5th Ibero-American Summit discusses the current challenges facing research and the significant lack of investment for respiratory diseases.”
Shane Fitch, President, Lovexair Foundation
15:30 – 16:00 hs (CET)
The map of respiratory health research Where are we and where are we going?
4:00 p.m. – 5:00 p.m. (CET)
Research from the
academic-scientific perspective
17:00 – 18:00 hs (CET)
Research from the care perspective
18:00 – 19:00 hs (CET)
Research from the
industry perspective
15:00 – 16:00 hs (CET)
The research of the future
16:00 – 17:00 hs (CET)
Research from the perspective of patients and family members
17:00 – 18:00 hs (CET)
Redefining the map of priorities in respiratory health research in Iberoamerica
18:00 – 18:30 hs (CET)
Keys to boosting research
Dr. Francisco García
President of SEPAR (Spanish Society of Pneumology and Thoracic Surgery).
Dr. Francisco Arancibia
President of ALAT (Latin American Association of Thorax)
Dr. Tomás Chivato
Dean of the Faculty of Medicine, Universidad CEU San Pablo (Spain)
Dr. Kevin O’Brien
Senior Medical Director Therapeutic Science and Strategy Unit in IQVIA
Mr. Juan Carlos López Caro
President of GRAP – Grupo Respiratorio de Atención Primaria (Primary Care Respiratory Group) (Spain)
Dr. Esther Barreiro
Pulmonologist and Coordinator of the Chronic Respiratory Diseases Research Group, Hospital del Mar-IMIMIM (Spain).
Juan Carrión
President of FEDER-Spanish Federation of Rare Diseases and founding member of ALIBER-Alianza Iberoamericana de Enfermedades Raras.
Dr. Anahí Yáñez
Medical Director of InaER Investigación en Alergia y Enfermedades Respiratorias (Argentina).
Silvia Caño Alcaina
Senior Project Director for Scientific and Clinical Innovations AstraZeneca (Spain)
Dr. Amelia Martin Uranga
Associate Director of Clinical and Translational Research at Farmaindustria (Spain).
Carlos Jaime
Managing Director France & Iberia Ascom (Spain-Portugal)
Dr. Nicole Hass
Spokesperson and technical advisor for APEPOC – COPD Patients Association (Spain).
Dr. Beatriz Martínez-Delgado
Scientific researcher IIER-Instituto de Investigación de Enfermedades Raras (Spain).
Dimitris Kontopidis
New president-elect of ELF – European Lung Foundation
Dr. Joan Soriano
Epidemiologist, Pneumology Department, Hospital La Princesa (Spain).
Dr. Jose Roberto Jardim
Pneumologist at the Federal University of Sao Paulo (Brazil).
Jennifer MacDonald
Lovexair Foundation Ambassador and Alpha-1 patient (Mexico)
Sabrina Brignardello
Global Head of Recruitment Department of Un ensayo para mí (Argentina)
Dina Grajales
President of Fundación Ayúdanos a Respirar (Colombia) and patient with PH.
Andoni Lorenzo Garmendia
President of the FEP-Spanish Patients’ Forum (Spain)
Dr. Maria Molina
Scientific Director of the Respiratory Diseases Area of CIBER (Centro de Investigación Biomédica en Red).
Dr. Justino Regalado
Medical Director of INER (National Institute of Respiratory Diseases).
Dayana Lago
Psychologist and Cystic Fibrosis Patient
Dr. Susana Baldini
Medical Director of CAEME – Argentine Chamber of Medicinal Specialties
Prof. Adrián LLerena MD PhD
Director INUBE Instituto Universitario de Investigación Biosanitaria de Extremadura (Extremadura University Institute for Biosanitary Research)
Bernard Gaspar
President of the Spanish Association of People Affected by Lung Cancer